semaglutide shortage november 2025 news Wegovy, Ozempic declared over, hitting copycats like Hims & Hers Semaglutide Shortage Ends: Compounded Versions

Conflicting Data: While some clinical trials suggested a minor increase in risk, many large-scale "real-world" studies have found no statistically significant difference in pancreatitis risk when comparing GLP-1 users to those on other diabetes treatments

They are trained to interpret these patterns and decide if a schedule adjustment is medically appropriate

Quality Payment Program Measures When code E11.69 is part of the patient's diagnoses the following Quality Measures apply and affect reimbursement

These are significant reductions compared to premium branded therapy

The Therapeutic Goods Administration (TGA) has updated its product warnings for GLP-1 RAs, saying they have potential to cause a rare but severe eye condition

This represents success, not failure